课题基金 / 基金详情

Wildlife disease ecology and gamebird management: a one health approach to Lyme disease

Wildlife disease ecology and gamebird management: a one health approach to Lyme disease
野生动物疾病生态学和猎鸟管理:莱姆病的单一健康方法
批准号:
2580209
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Wildlife is an important source of emerging human diseases. A One Health approach that integrates animal, human and environmental health is thus key for understanding the ecology of emerging zoonotic diseases as well as successful disease control and management. Lyme disease is the most common tick-borne disease in the northern hemisphere. The number of human Lyme cases has increased rapidly in recent years, leading to public health concern. Pheasants are released in large numbers for recreational hunting in the UK. These birds can harbour large numbers of ticks and are particularly competent reservoir hosts for Borrelia, the causative agent of Lyme disease. A growing body of research is investigating the ecological effects of released gamebirds on habitats and native wildlife. Surprisingly, however, the consequences of gamebird releases for zoonotic disease dynamics and human infection risk have so far been neglected.The aim of this project is to test how gamebird releases affect Lyme disease risk across the UK and how management practices can influence vector abundance and transmission dynamics. This multidisciplinary project provides opportunities to combine ecological fieldwork (e.g. sampling of pheasants and other wildlife hosts, monitoring of tick populations), molecular techniques (e.g. detection of Borrelia infection using qPCR) and spatial modelling to addresses fundamental questions in disease ecology and community ecology, with important applied opportunities for wildlife management and human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
黏液层/细菌被膜双重渗透型抗菌聚多肽纳米载体用于肺部给药治疗慢性阻塞性肺病
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    虞桂平
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    彭奕冰
  • 依托单位: